Apligraf pressure sore trials imminent:
This article was originally published in Clinica
Organogenesis is to begin clinical trials in the new year of its Apligraf manufactured skin product to treat pressure sores. The FDA is considering the use of Apligraf, formerly known as Graftskin, in venous ulcers. US studies with diabetic ulcers are underway (see Clinica No 776, p 17). Apligraf is marketed in Canada for venous ulcers by Novartis Pharmaceuticals.